Coexisting subacute and systemic lupus erythematosus after terbinafine administration: Successful treatment with mycophenolate mofetil

International Journal of Dermatology

Volumn 45, Issue 3, 2006, Pages 320-322

  Cetkovská, Petra ^a   Pizinger, Karel ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; FAMOTIDINE; MELOXICAM; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TERBINAFINE;

ADULT; ARTHRITIS; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; COMORBIDITY; DISEASE EXACERBATION; DRUG ERUPTION; DRUG WITHDRAWAL; ERYTHEMA; FATIGUE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE TEST; MYALGIA; ONYCHOMYCOSIS; PATIENT COUNSELING; RISK FACTOR; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACUTE DISEASE; ADULT; ANTIFUNGAL AGENTS; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; NAPHTHALENES; ONYCHOMYCOSIS;

EID: 33644745203     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02472.x     Document Type: Article

References (9)

1. Callen JP. Drug-induced cutaneous lupus erythematosus, a distinct syndrome that is frequently unrecognized. J Am Acad Dermatol 2001; 45: 315-316.
2. Hutchinson TA, Shahan DR (eds). Terbinafine. Drugdex® System. Greenwood Village, CO: Micromedex.
3. Bonsmann G, Schiller M, Luger T.A., et al. Terbinafine-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 2001; 44: 925-931.
4. Callen JP, Hughes AP, Kulp-Shorten C. Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine. Arch Dermatol 2001; 137: 1196-1198.
5. Brooke R, Coulson I.H., Dawoud A. Terbinafine-induced subacute cutaneous lupus erythematosus. Br J Dermatol 1998; 139: 1132-1133.
6. Holmes S, Kemmett D. Exacerbation of systemic lupus erythematosus induced by terbinafine. Br J Dermatol 1998; 139: 1133.
7. Litt J. Drug Eruption Reference Manual. New York: Parthenon Publishing, 2001; 326-327.
8. Srivastava M, Rencic A, Diglio G, et al. Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus. Arch Dermatol 2003; 139: 45-49.
9. Schanz S, Ulmer A, Rassner G, et al. Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil. Br J Dermatol 2002; 147: 174-178.